Encompass Health Stock

Encompass Health EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Encompass Health (EHC) as of Aug 2, 2026 is 9.42. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 12.82 — a change of -26.51% (lower).

EV/EBIT

9.42

YoY

-26.51%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Encompass Health is 2026 9.42 . EV/EBIT (Enterprise Value to EBIT) of Encompass Health was 2025 12.82 . It decreases by -26.51% lower compared to the previous year.

The Encompass Health EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
9.95 base
Jan 1, 2020
12.51 base
Jan 1, 2021
9.92 base
Jan 1, 2022
9.57 base
Jan 1, 2023
8.99 base
Jan 1, 2024
10.93 base
Jan 1, 2025
9.20 base
Jan 1, 2026 (e)
10.90 base
YEARPRICE-TO-EBIT
2026 est 10.90
2025 9.20
2024 10.93
2023 8.99
2022 9.57
2021 9.92
2020 12.51
2019 9.95
2018 9.05
2017 7.55
2016 6.31
2015 6.32
2014 8.32
2013 7.32
2012 4.80
2011 4.46
2010 6.85
2009 6.28
2008 2.36
2007 8.81
2006 26.21
Access this data via the Eulerpool API
Get Free API Key

Encompass Health Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Encompass Health's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Encompass Health's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Encompass Health's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Encompass Health grows earnings faster than its peers.

Encompass Health Stock analysis

What does Encompass Health do? Encompass Health Corp is an American company that provides healthcare services for patients with complex medical needs. The company was founded in 1984 in Birmingham, Alabama and has since become a leading provider of rehabilitation services in the USA and Puerto Rico. Encompass Health's business model is based on providing acute care rehabilitation and nursing for patients suffering from severe injuries, illnesses, or other traumatic events. The company offers services such as physical, occupational, and speech therapy rehabilitation, medical nursing, and palliative care. Encompass Health is divided into four divisions: rehabilitation facilities, home health, hospice and palliative care, and a group purchasing organization. In each division, the company offers a wide range of products and services to meet the needs of patients and customers. Encompass Health has taken a pioneering role in introducing new technologies and treatment methods in the field of rehabilitation and nursing. The company continuously invests in developing innovative solutions to improve the health and well-being of its patients. Encompass Health employs approximately 42,000 employees in the USA and is headquartered in Birmingham, Alabama. It is listed on the New York Stock Exchange under the ticker symbol EHC. Overall, Encompass Health Corp is a leading provider of healthcare services and solutions in the USA, well-positioned to continue playing an important role in the industry in the future. Encompass Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Encompass Health stock

EV/EBIT (Enterprise Value to EBIT) of Encompass Health is 9.42 in 2026.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Encompass Health

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Encompass Health